120 related articles for article (PubMed ID: 25623744)
1. Bone Metastasis in Renal Cell Carcinoma is Preprogrammed in the Primary Tumor and Caused by AKT and Integrin α5 Signaling.
Haber T; Jöckel E; Roos FC; Junker K; Prawitt D; Hampel C; Thüroff JW; Brenner W;
J Urol; 2015 Aug; 194(2):539-46. PubMed ID: 25623744
[TBL] [Abstract][Full Text] [Related]
2. miR‑205 suppresses cell proliferation, invasion, and metastasis via regulation of the PTEN/AKT pathway in renal cell carcinoma.
Wang H; Chen B; Duan B; Zheng J; Wu X
Mol Med Rep; 2016 Oct; 14(4):3343-9. PubMed ID: 27498834
[TBL] [Abstract][Full Text] [Related]
3. Migration of renal tumor cells depends on dephosphorylation of Shc by PTEN.
Schneider E; Keppler R; Prawitt D; Steinwender C; Roos FC; Thüroff JW; Lausch E; Brenner W
Int J Oncol; 2011 Mar; 38(3):823-31. PubMed ID: 21206972
[TBL] [Abstract][Full Text] [Related]
4. NOTCH1 functions as an oncogene by regulating the PTEN/PI3K/AKT pathway in clear cell renal cell carcinoma.
Liu S; Ma X; Ai Q; Huang Q; Shi T; Zhu M; Wang B; Zhang X
Urol Oncol; 2013 Aug; 31(6):938-48. PubMed ID: 21993533
[TBL] [Abstract][Full Text] [Related]
5. High calcium concentration in bones promotes bone metastasis in renal cell carcinomas expressing calcium-sensing receptor.
Joeckel E; Haber T; Prawitt D; Junker K; Hampel C; Thüroff JW; Roos FC; Brenner W
Mol Cancer; 2014 Feb; 13():42. PubMed ID: 24576174
[TBL] [Abstract][Full Text] [Related]
6. Renal tumor-derived exosomes inhibit hepaCAM expression of renal carcinoma cells in a p-AKT-dependent manner.
Jiang XL; Zhang Y; Tan B; Luo CL; Wu XH
Neoplasma; 2014; 61(4):416-23. PubMed ID: 24645843
[TBL] [Abstract][Full Text] [Related]
7. Ghrelin promotes renal cell carcinoma metastasis via Snail activation and is associated with poor prognosis.
Lin TC; Liu YP; Chan YC; Su CY; Lin YF; Hsu SL; Yang CS; Hsiao M
J Pathol; 2015 Sep; 237(1):50-61. PubMed ID: 25925728
[TBL] [Abstract][Full Text] [Related]
8. Low expression of phosphatase and tensin homolog in clear‑cell renal cell carcinoma contributes to chemoresistance through activating the Akt/HDM2 signaling pathway.
Chen J; Zhu H; Zhang Y; Cui MH; Han LY; Jia ZH; Wang L; Teng H; Miao LN
Mol Med Rep; 2015 Aug; 12(2):2622-8. PubMed ID: 25954860
[TBL] [Abstract][Full Text] [Related]
9. Dicer is down-regulated in clear cell renal cell carcinoma and in vitro Dicer knockdown enhances malignant phenotype transformation.
Ma X; Fan Y; Gao Y; Zhang Y; Huang Q; Ai Q; Ni D; Chen W; Zhang P; Song E; Wang B; Shi T; Zheng T; Zhang X
Urol Oncol; 2014 Jan; 32(1):46.e9-17. PubMed ID: 24094887
[TBL] [Abstract][Full Text] [Related]
10. Characterization of a renal cell carcinoma cell line derived from a human bone metastasis and establishment of an experimental nude mouse model.
Weber KL; Pathak S; Multani AS; Price JE
J Urol; 2002 Aug; 168(2):774-9. PubMed ID: 12131367
[TBL] [Abstract][Full Text] [Related]
11. In renal cell carcinoma the PTEN splice variant PTEN-Δ shows similar function as the tumor suppressor PTEN itself.
Breuksch I; Welter J; Bauer HK; Enklaar T; Frees S; Thüroff JW; Hasenburg A; Prawitt D; Brenner W
Cell Commun Signal; 2018 Jun; 16(1):35. PubMed ID: 29954386
[TBL] [Abstract][Full Text] [Related]
12. Expression of CX3CR1 associates with cellular migration, metastasis, and prognosis in human clear cell renal cell carcinoma.
Yao X; Qi L; Chen X; Du J; Zhang Z; Liu S
Urol Oncol; 2014 Feb; 32(2):162-70. PubMed ID: 23570708
[TBL] [Abstract][Full Text] [Related]
13. PTEN and p27Kip1 are not downregulated in the majority of renal cell carcinomas--implications for Akt activation.
Hennenlotter J; Ohneseit PA; Simon P; Merseburger AS; Serth J; Kuehs U; Kramer M; Hartmann JT; Stenzl A; Kuczyk MA
Oncol Rep; 2008 May; 19(5):1141-7. PubMed ID: 18425369
[TBL] [Abstract][Full Text] [Related]
14. Alterations in enhancer of zeste homolog 2, matrix metalloproteinase-2 and tissue inhibitor of metalloproteinase-2 expression are associated with ex vivo and in vitro bone metastasis in renal cell carcinoma.
Wang J; Ren Y; Guo X; Cheng H; Ye Y; Qi J; Yang C; You H
Mol Med Rep; 2015 May; 11(5):3585-92. PubMed ID: 25571919
[TBL] [Abstract][Full Text] [Related]
15. Resistance to the mTOR inhibitor temsirolimus alters adhesion and migration behavior of renal cell carcinoma cells through an integrin α5- and integrin β3-dependent mechanism.
Juengel E; Makarević J; Reiter M; Mani J; Tsaur I; Bartsch G; Haferkamp A; Blaheta RA
Neoplasia; 2014 Apr; 16(4):291-300. PubMed ID: 24862756
[TBL] [Abstract][Full Text] [Related]
16. Expression of molecular markers associated with the mammalian target of rapamycin pathway in nonmetastatic renal cell carcinoma: Effect on prognostic outcomes following radical nephrectomy.
Nishikawa M; Miyake H; Harada K; Fujisawa M
Urol Oncol; 2014 Jan; 32(1):49.e15-21. PubMed ID: 24239474
[TBL] [Abstract][Full Text] [Related]
17. Autocrine and paracrine STIP1 signaling promote osteolytic bone metastasis in renal cell carcinoma.
Wang J; You H; Qi J; Yang C; Ren Y; Cheng H
Oncotarget; 2017 Mar; 8(10):17012-17026. PubMed ID: 28199984
[TBL] [Abstract][Full Text] [Related]
18. MicroRNA-218 inhibits cell migration and invasion in renal cell carcinoma through targeting caveolin-2 involved in focal adhesion pathway.
Yamasaki T; Seki N; Yoshino H; Itesako T; Hidaka H; Yamada Y; Tatarano S; Yonezawa T; Kinoshita T; Nakagawa M; Enokida H
J Urol; 2013 Sep; 190(3):1059-68. PubMed ID: 23454155
[TBL] [Abstract][Full Text] [Related]
19. Activation of PI3K is associated with reduced survival in renal cell carcinoma.
Merseburger AS; Hennenlotter J; Kuehs U; Simon P; Kruck S; Koch E; Stenzl A; Kuczyk MA
Urol Int; 2008; 80(4):372-7. PubMed ID: 18587247
[TBL] [Abstract][Full Text] [Related]
20. MicroRNAs with prognostic potential for metastasis in clear cell renal cell carcinoma: a comparison of primary tumors and distant metastases.
Heinzelmann J; Unrein A; Wickmann U; Baumgart S; Stapf M; Szendroi A; Grimm MO; Gajda MR; Wunderlich H; Junker K
Ann Surg Oncol; 2014 Mar; 21(3):1046-54. PubMed ID: 24242678
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]